Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01031342 · ClinicalTrials.gov registry record · NA

Early Colonoscopy for Lower Gastrointestinal (GI) Bleeding

A NA study, sponsored by University of Southern California.

Terminated
Registry status
NA
Development phase
72
Enrollment target

NCT01031342: Clinical Trial NA study, sponsored by University of Southern California.

NCT01031342 is a NA study that was terminated before completion, run by University of Southern California. The registered enrollment target is 72 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01031342, a NA study, was terminated before completion, sponsored by University of Southern California.

TERMINATED
Registry status
NA
Development phase
72 participants
Enrollment target

Study Summary

Study hypothesis is that performing early colonoscopy in patients who present to the hospital with lower GI bleeding improves their outcome. Patients who are admitted with bleeding from their rectum and a negative endoscopic exam of the stomach and upper intestine are randomized (like flipping a coin) to receive a colonsoscopy either as an emergency (within 12 hours) or as a routine procedure (36 hours after admission). Patients are followed during their hospitalization to see if they have further bleeding, if they require blood transfusions, if they need other diagnostic tests, if they need surgery or other treatments, and how long they stay in the hospital.

Interventions

  • PROCEDURE Early colonoscopy
  • PROCEDURE Elective colonoscopy

Trial Details

FieldValue
Enrollment Target 72 participants
Start Date 2002-08
Est. Completion 2009-11
Phase NA
University of Southern California

617 total trials

Why NCT01031342 stopped before completion

NCT01031342 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 72 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 2 interventions - of which Early colonoscopy is the first listed.

NCT01031342 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01031342 about?

NCT01031342 is a clinical study titled "Early Colonoscopy for Lower Gastrointestinal (GI) Bleeding". Study hypothesis is that performing early colonoscopy in patients who present to the hospital with lower GI bleeding improves their outcome. Patients who are admitted with bleeding from their rectum and a negative endoscopic exam of the stomach and upper intestine are randomized (like flipping a co...

What is the current status of trial NCT01031342?

This trial is currently terminated. It is a NA study. The enrollment target is 72 participants. The study started on 2002-08. Estimated completion is 2009-11.

What interventions are being tested in trial NCT01031342?

The interventions under investigation include: Early colonoscopy (PROCEDURE), Elective colonoscopy (PROCEDURE).

Who is sponsoring clinical trial NCT01031342?

This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01031342's enrollment target sits among peer trials

72 1089th of 2000 higher than 899 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02359253 · 72 participants · NA

    Robot Aided Rehabilitation - Intervention

  • NCT02962661 · 72 participants · Phase 1

    Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines

  • NCT03113643 · 72 participants · Phase 1

    SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

  • NCT03187535 · 72 participants · NA

    Effect of TEAS on PONV After Spinal Surgery

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01031342, the US trial registry maintained by the National Library of Medicine. NCT01031342 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.